You have to believe JT knew an Adcom was coming though he specifically put out a press release saying they thought unlikely and in the filing for the shares they stated that one of the risks besides and Adcom is a delay in approval date, but added the fact that was highly unlikely or similar wording.
It was very clear to me on the call last night, very clear to me in the Q2 call that JT did not expect an Adcom because it was so late in the process. Otherwise he could now go to jail, why put yourself at risk of going to prison by knowing an Adcom is highly likely and lie about while raising money for the company?
The bankers on the raise advised them to do the raise, it's not unusual to raise money before a launch and when you have the stock at a 52 week high just before raise announcement. It's also not a JT only call, there is a management team, the board and probably input from large shareholders such as BB.
It's unusual for FDA to delay a date in the past few years but does happen, a few years ago delaying PR approval dates was happening a lot.
People are letting emotions take over, step back, look at it from afar, the MO issue keeps coming up, the indication is huge, the label request from Amarin is very broad, the filing was very large and takes time for FDA to go through, the FDA is not very efficient, lots of reasons things happened this way that don't need dark, dark, dark thoughts.
I admit the news is NOT positive, for sure, and the added wait is excruciating, but too many positives here to expect a negative outcome in the end. And then they need to sell the company to the highest bidder.
News 
Market Data 
Discover 
